Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia | Zendy

Marc S. Sabatine | Zendy; Emerson Liu | Zendy; David A. Morrow | Zendy; Eric Heller | Zendy; Robert McCarroll | Zendy; Roger C. Wiegand | Zendy; Gabriel F. Berriz | Zendy; Frederick P. Roth | Zendy; Robert E. Gerszten | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia

Author(s) -

Marc S. Sabatine,

Emerson Liu,

David A. Morrow,

Eric Heller,

Robert McCarroll,

Roger C. Wiegand,

Gabriel F. Berriz,

Frederick P. Roth,

Robert E. Gerszten

Publication year - 2005

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.569137

Subject(s) - medicine , metabolomics , ischemia , metabolome , coronary artery disease , metabolic pathway , catabolism , lactic acid , cardiology , bioinformatics , metabolism , metabolite , biology , genetics , bacteria

Recognition of myocardial ischemia is critical both for the diagnosis of coronary artery disease and the selection and evaluation of therapy. Recent advances in proteomic and metabolic profiling technologies may offer the possibility of identifying novel biomarkers and pathways activated in myocardial ischemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research